Skip to main content
EJNMMI Research
Fig.2 | EJNMMI Research

Fig.2

From: Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes

Fig.2

The differentiation status of megakaryocytes in three cell culture batches (MK1-3) assessed by flow cytometry. Of the three megakaryocytic cell culture batches from three different healthy adult HSPC donors (MK1-3), MK3 has both the most megakaryocytes and the most mature megakaryocytes after 9 days of differentiation. The results were based on flow cytometry expression of the cell surface antigens CD34, CD41a, CD42a, a marker of true megakaryocytic commitment, and CD42b, a marker of more mature megakaryocytes

Back to article page